AlzeCure reveals positive NeuroRestore ACD856 data
Therapy is a positive modulator and has demonstrated that it can improve learning and memory
Read More
Tag: ACD856
AlzeCure demonstrates disease-modifying effects of NeuroRestore ACD856
Data from the study shows that ACD856 has a potential neuroprotective effect in a cellular mode
Read More
AlzeCure’s ACD856 research shows positive impact on brain
Exploratory central nervous system analysis shows that ACD856 increases activity in brain
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
